← All trials
NCT05356091
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 2, 2022
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- May 2, 2022
- Last posted
- Dec 21, 2022
- Enrollment
- 36
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kangbuk Samsung HospitalLead sponsor
- Hana Pharmaceutical Co., LtdCollaborator
- Kangbuk Samsung HospitalReponsible party - principal investigator
- Kangbuk Samsung HospitalSponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.